These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3728282)

  • 21. DL and D sotalol decrease defibrillation energy requirements.
    Wang M; Dorian P
    Pacing Clin Electrophysiol; 1989 Sep; 12(9):1522-9. PubMed ID: 2476781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical experiences with bretylium tosylate].
    Steffen V; Assmann I; Fiehring H
    Z Gesamte Inn Med; 1976 Sep; 31(17):684-8. PubMed ID: 793213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bretylium: a prototype for future development of antidysrhythmic agents.
    Patterson E; Lucchesi BR
    Am Heart J; 1983 Aug; 106(2):426-31. PubMed ID: 6869235
    [No Abstract]   [Full Text] [Related]  

  • 24. Postmyocardial infarction re-entrant ventricular arrhythmias in conscious dogs: suppression by bretylium tosylate.
    Patterson E; Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1981 Mar; 216(3):453-8. PubMed ID: 7205624
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of chronic canine ventricular tachyarrhythmias with bretylium tosylate.
    Patterson E; Gibson JK
    Circulation; 1981 Nov; 64(5):1045-50. PubMed ID: 7285294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bretylium in hypothermia-induced ventricular fibrillation in dogs.
    Elenbaas RM; Mattson K; Cole H; Steele M; Ryan J; Robinson W
    Ann Emerg Med; 1984 Nov; 13(11):994-9. PubMed ID: 6486552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bretylium tosylate versus lidocaine in experimental cardiac arrest.
    Vachiery JL; Reuse C; Blecic S; Contempré B; Vincent JL
    Am J Emerg Med; 1990 Nov; 8(6):492-5. PubMed ID: 2222590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anesthetized rabbit as a model for ischemia- and reperfusion-induced arrhythmias: effects of quinidine and bretylium.
    Coker SJ
    J Pharmacol Methods; 1989 Jul; 21(4):263-79. PubMed ID: 2755145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of the effect of bretylium on the ventricular fibrillation threshold in dogs.
    Euler DE; Scanlon PJ
    Am J Cardiol; 1985 May; 55(11):1396-401. PubMed ID: 3993577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of quinidine in fibrillation and defibrillation of the canine heart.
    JENKINS LB; NIGELS FE; BOONE JA
    Surg Forum; 1953 Oct; 4():104-8. PubMed ID: 13187249
    [No Abstract]   [Full Text] [Related]  

  • 31. Management of ventricular dysrhythmias in the prehospital and emergency department setting.
    Mayer NM
    Am J Cardiol; 1984 Jul; 54(2):34A-36A. PubMed ID: 6464998
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation.
    Chow MS; Kluger J; Lawrence R; Fieldman A
    Proc Soc Exp Biol Med; 1986 May; 182(1):63-7. PubMed ID: 3083422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of bretylium to suppress inducible ventricular tachycardia.
    Greene HL; Werner JA; Gross BW; Sears GK
    Am Heart J; 1983 May; 105(5):717-21. PubMed ID: 6846114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Success rate versus defibrillation energy: temporal profile and the most efficient defibrillation threshold.
    Murakawa Y; Gliner BE; Thakor NV
    Am Heart J; 1989 Sep; 118(3):451-8. PubMed ID: 2773769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of an unsuccessful subthreshold shock on the energy requirement for the subsequent defibrillation.
    Murakawa Y; Gliner BE; Shankar B; Thakor NV
    Am Heart J; 1989 May; 117(5):1065-9. PubMed ID: 2711966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac arrhythmias produced by bretylium in cats anesthetized with halothane.
    Condouris GA; Ortiz J; Lyness W
    Eur J Pharmacol; 1979 Apr; 55(1):93-7. PubMed ID: 35358
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute effects of intravenous propafenone on the internal ventricular defibrillation threshold in the anesthetized dog.
    Peters W; Gang ES; Okazaki H; Solingen S; Kobayashi Y; Karagueuzian HS; Mandel WJ
    Am Heart J; 1991 Nov; 122(5):1355-60. PubMed ID: 1951000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The defibrillation threshold: a comparison of anesthetics and measurement methods.
    Gill RM; Sweeney RJ; Reid PR
    Pacing Clin Electrophysiol; 1993 Apr; 16(4 Pt 1):708-14. PubMed ID: 7683796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barium decreases defibrillation energy requirements.
    Dorian P; Witkowski FX; Penkoske PA; Feder-Elituv RS
    J Cardiovasc Pharmacol; 1994 Jan; 23(1):107-12. PubMed ID: 7511721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.